Beckman Coulter/Princeton BioMeditech agreement

Sunday, 16 October, 2005


In a move that underscores its growing commitment to the market for rapid diagnostic medical test products, Beckman Coulter has entered into a supply relationship with Princeton BioMeditech (PBM). Under the agreement, PBM will supply a wide range of rapid diagnostic tools used at the point of medical care to Beckman Coulter's Primary Care Diagnostics business unit (PCD).

Princeton BioMeditech is a leading innovator and manufacturer of simple and rapid diagnostic products used at the point of care. The company offers more than 70 tests covering fertility management, infectious diseases, cardiac markers, drugs of abuse, cancer markers, environmental and veterinary diagnostics that enable consumers and professionals to improve speed and quality of diagnosis for better patient care.

Related News

Over $40m funding for health and medical research projects

Awarded to only the highest-performing researchers of any career stage, NHMRC Investigator Grants...

Award winners announced for 2020 World Metrology Day

20 May was World Metrology Day, celebrating the central role of metrology, or measurement...

Thermo Fisher ramps up response to COVID-19

Serving science company Thermo Fisher Scientific has announced several new measures as part of...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd